Machine Learning Times
EXCLUSIVE HIGHLIGHTS
You Must Address These 4 Concerns To Deploy Predictive AI
 Originally published in Forbes Most predictive AI projects fail to launch into production. The...
Hybrid AI: Industry Event Signals Emerging Hot Trend
 Originally published in Forbes After decades chairing and keynoting myriad...
Predictive AI Thrives, Despite GenAI Stealing The Spotlight
 Originally published in Forbes Generative AI and predictive AI ought...
For Managing Business Uncertainty, Predictive AI Eclipses GenAI
  Originally published in Forbes The future is the ultimate...
SHARE THIS:

11 years ago
Wise Practitioner – Predictive Analytics Interview Series: Scott Jelinsky of Pfizer, Inc.

 In anticipation of his upcoming conference presentation at Predictive Analytics World for Healthcare Boston, Sept 27-Oct 1, 2015, we asked Scott Jelinksy, Principal Research Scientist at Pfizer, Inc., a few questions about incorporating predictive analytics into healthcare. Catch a glimpse of his presentation, Crowdsourcing Predictive Analytics to Enhance Clinical Trial Design, and see what’s in store for the second annual PAW Healthcare conference in Boston. Q: In your work with predictive analytics, what area of healthcare are you focused on? A: We use predictive analytics to support a variety of different areas of health care, but our primary interest is

This content is restricted to site members. If you are an existing user, please log in on the right (desktop) or below (mobile). If not, register today and gain free access to original content and industry news. See the details here.

Comments are closed.